Endothelial cells guided by immobilized gradients of vascular endothelial growth factor on porous collagen scaffolds

被引:65
作者
Odedra, Devang [1 ,2 ]
Chiu, Loraine L. Y. [2 ]
Shoichet, Molly [1 ,2 ,3 ,4 ]
Radisic, Milica [1 ,2 ,5 ]
机构
[1] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada
[2] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada
[3] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada
[4] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada
[5] Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Gradient; Vascular endothelial growth factor; Tissue engineering; Collagen; Immobilization; ENGINEERED HEART-TISSUE; CARDIAC-MUSCLE TISSUE; IN-VITRO; SURVIVAL; OXYGEN; STIMULATION; TEMPLATES; CONSTRUCT; MYOCYTES; IMPROVES;
D O I
10.1016/j.actbio.2011.05.002
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A key challenge in tissue engineering is overcoming cell death in the scaffold interior due to the limited diffusion of oxygen and nutrients therein. We here hypothesize that immobilizing a gradient of a growth/ survival factor from the periphery to the center of a porous scaffold would guide endothelial cells into the interior of the scaffold, thus overcoming a necrotic core. Proteins were immobilized by one of three methods on porous collagen scaffolds for cardiovascular tissue engineering. The proteins were first activated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/sulfo N-hydroxysuccinimide and then applied to the scaffold by one of three methods to establish the gradient: perfusion (the flow method), use of a source and a sink (the source-sink method) or by injecting 5 mu l of the solution at the center of the scaffold (point source method). Due to the high reproducibility and ease of application of the point source method it was further used for VEGF-165 gradient formation, where an similar to 2 ng ml(-1) mm(-1) gradient was formed in a radial direction across a scaffold, 12 mm in diameter and 2.5 mm thick. More endothelial cells were guided by the VEGF-165 gradient deep into the center of the scaffold compared with both uniformly immobilized VEGF-165 (with the same total VEGF concentration) and VEGF-free controls. All scaffolds (including the controls) yielded the same number of cells, but notably the VEGF-165 gradient scaffolds demonstrated a higher cell density in the centre. Thus we concluded that the VEGF-165 gradient promoted the migration, but not proliferation, of cells into the scaffold. These gradient scaffolds provide the foundation for future in vivo tissue engineering studies. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:3027 / 3035
页数:9
相关论文
共 52 条
  • [1] Endothelial Cell Guidance in 3D Patterned Scaffolds
    Aizawa, Yukie
    Wylie, Ryan
    Shoichet, Molly
    [J]. ADVANCED MATERIALS, 2010, 22 (43) : 4831 - +
  • [2] Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering
    Asakawa, Nahoko
    Shimizu, Tatsuya
    Tsuda, Yukiko
    Sekiya, Sachiko
    Sasagawa, Tadashi
    Yamato, Masayuki
    Fukai, Fumio
    Okano, Teruo
    [J]. BIOMATERIALS, 2010, 31 (14) : 3903 - 3909
  • [3] *ASS AH, 2004, HEART DIS STROK STAT
  • [4] Protein-based signaling systems in tissue engineering
    Boontheekul, T
    Mooney, DJ
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2003, 14 (05) : 559 - 565
  • [5] Pulsatile perfusion bioreactor for cardiac tissue engineering
    Brown, Melissa A.
    Iver, Rohin K.
    Radisic, Milica
    [J]. BIOTECHNOLOGY PROGRESS, 2008, 24 (04) : 907 - 920
  • [6] Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies
    Bursac, N
    Papadaki, M
    Cohen, RJ
    Schoen, FJ
    Eisenberg, SR
    Carrier, R
    Vunjak-Novakovic, G
    Freed, LE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (02): : H433 - H444
  • [7] Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO
  • [8] 2-X
  • [9] Perfusion improves tissue architecture of engineered cardiac muscle
    Carrier, RL
    Rupnick, M
    Langer, R
    Schoen, FJ
    Freed, LE
    Vunjak-Novakovic, G
    [J]. TISSUE ENGINEERING, 2002, 8 (02): : 175 - 188
  • [10] Effects of oxygen on engineered cardiac muscle
    Carrier, RL
    Rupnick, M
    Langer, R
    Schoen, FJ
    Freed, LE
    Vunjak-Novakovic, G
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2002, 78 (06) : 617 - 625